Market

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones

Adverum Biotechnologies Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Pipeline Highlights and Updates to Anticipated Milestones
Read More

Related Posts

SS&C Technologies director Michael Zamkow sells $2.03 million in stock

SS&C Technologies director Michael Zamkow sells $2.03 m...

Alliance Entertainment CEO Jeffrey Walker buys $2.69 billion in stock

Alliance Entertainment CEO Jeffrey Walker buys $2.69 bi...

Virgin Galactic’s new spacecraft looms large as company eyes future profitability

Virgin Galactic’s new spacecraft looms large as company...

Rocket Lab makes ‘bold’ satellite move, but shares slide on weak outlook

Rocket Lab makes ‘bold’ satellite move, but shares slid...

Japan factory output contracts as expected in Jan, retail sales jump

Japan factory output contracts as expected in Jan, reta...

Factbox-Key economic targets expected to be approved by China's parliament

Factbox-Key economic targets expected to be approved by...